News

February 11, 2020

Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Lewis Katz School of Medicine at Temple University for the Potential Use of KLS-13019 in the Treatment of CIPN

January 28, 2020

Kannalife, Inc. CEO Recaps 2019 Advances and Potential Ahead

January 22, 2020

Kannalife, Inc. Issues Update on Intellectual Property and Patent Estate

January 14, 2020

Kannalife, Inc. Further Elucidates Mechanism of Action Behind KLS-13019, the Company’s Leading Drug Candidate for the Potential Treatment of Neuropathic Pain

January 7, 2020

Kannalife Secures New INCI Name for its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

December 18, 2019

CBD: Perils, Promise and Development for Neuropathic Pain

December 11, 2019

Kannalife, Inc. Announces Filing of U.S. Patent 62/934,861 – Functionalized 1, 3 Benzene Diols and Their Method of Use for the Treatment of Radiation Dermatitis and Other Skin Disorders

December 9, 2019

Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol “KLFE”

June 27, 2019

Kannalife, Inc. to Present Breakthrough CIPN Study Findings on the Comparison of KLS-13019 to CBD at 29th Annual International Cannabinoid Research Society Conference

May 21, 2019

Kannalife Inc. Publishes New Research on Chemotherapy-Induced Peripheral Neuropathy

March 24, 2019

Kannalife Spokesman former NFL kicker Nick Lowery on Head Injuries, CBD Treatment

January 16, 2019

Kannalife Announces Completion of Name Change, Ticker Symbol Change

August 1, 2018

Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

June 26, 2018

Kannalife mentioned in BioSpace on the First Cannabis-Based Drug receives FDA Approval

May 22, 2018

Dateline NBC with Lester Holt profiles Kannalife on show “Growing Promise”

May 18, 2018

Kannalife Sciences to be Featured in Dateline NBC Segment Covering Company’s Research on CBD-Like Molecules as Treatments for HE, CTE

April 26, 2018

Former NFL great Nick Lowery talks Kannalife on CNBC

October 30, 2017

Kannalife Spokesman Nick Lowery on Between the Lines

September 28, 2017

Nick Lowery of Kannalife Speaks With Tiki and Tierney about CTE – CBS Sports

July 6, 2017

Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium Company Presents Science Behind Mechanism of Action of CBD and its Own Patented CBD-derived Molecule KLS-13019